Role of biological assays in the diagnosis of Lyme borreliosis presentations. What are the techniques and which are currently available?;Place des méthodes biologiques dans le diagnostic des différentes manifestations de la borréliose de Lyme. Quelles sont les techniques ? Quelles sont celles disponibles actuellement ?

Medecine et Maladies Infectieuses

Volumn 37, Issue 7-8, 2007, Pages 496-506

  De Martino, S J ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Borrelia burgdorferi sensu lato; in vitro PCR; Western Blot

Indexed keywords

ANTIBODY DETECTION; ARTICLE; BACTERIUM CULTURE; BIOASSAY; BORRELIA BURGDORFERI; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; GENE AMPLIFICATION; HUMAN; IMMUNOBLOTTING; LABORATORY DIAGNOSIS; LYME DISEASE; NONHUMAN; POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SERUM; SPIROCHETE; STANDARD; WESTERN BLOTTING; ARTHRITIS; ENZYME IMMUNOASSAY; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; PHYSICAL EXAMINATION; REVIEW;

BACTERIAL VACCINE; LIPOPROTEIN; MEMBRANE ANTIGEN; OUTER MEMBRANE PROTEIN; OUTER SURFACE PROTEIN A;

ANTIGENS, SURFACE; ARTHRITIS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI GROUP; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOLOGIC TESTS; LIPOPROTEINS; LYME DISEASE; LYME NEUROBORRELIOSIS; PHYSICAL EXAMINATION;

EID: 34548413979     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2006.01.018     Document Type: Article

References (99)

1. Jurca T., Ruzic-Sabljic E., Lotric-Furlan S., Maraspin V., Cimperman J., Picken R.N., et al. Comparison of peripheral and central biopsy sites for the isolation of Borrelia burgdorferi sensu lato from erythema migrans skin lesions. Clin. Infect. Dis. 27 (1998) 636-638
2. Berger B.W., Johnson R.C., Kodner C., and Coleman L. Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J. Clin. Microbiol. 30 (1992) 359-361
3. Wormser G.P., Bittker S., Cooper D., Nowakowski J., Nadelman R.B., and Pavia C. Yield of large-volume blood cultures in patients with early Lyme disease. J. Infect. Dis. 184 (2001) 1070-1072
4. Maraspin V., Ruzic-Sabljic E., Cimperman J., Lotric-Furlan S., Jurca T., Picken R.N., et al. Isolation of Borrelia burgdorferi sensu lato from blood of patients with erythema migrans. Infection 29 (2001) 65-70
5. Wormser G.P., Nowakowski J., Nadelman R.B., Bittker S., Cooper D., and Pavia C. Improving the yield of blood cultures for patients with early Lyme disease. J. Clin. Microbiol. 36 (1998) 296-298
6. Stanek G., Klein J., Bittner R., and Glogar D. Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N. Engl. J. Med. 322 (1990) 249-252
7. Preac-Mursic V., Pfister H.W., Spiegel H., Burk R., Wilske B., Reinhardt S., et al. First isolation of Borrelia burgdorferi from an iris biopsy. J. Clin. Neuroophthalmol. 13 (1993) 155-161 (discussion 162)
8. Wormser G.P., Forseter G., Cooper D., Nowakowski J., Nadelman R.B., Horowitz H., et al. Use of a novel technique of cutaneous lavage for diagnosis of Lyme disease associated with erythema migrans. JAMA 268 (1992) 1311-1313
9. De Koning J., Bosma R.B., and Hoogkamp-Korstanje J.A. Demonstration of spirochaetes in patients with Lyme disease with a modified silver stain. J. Med. Microbiol. 23 (1987) 261-267
10. Ito F., Hunter E.F., George R.W., Swisher B.L., and Larsen S.A. Specific immunofluorescence staining of Treponema pallidum in smears and tissues. J. Clin. Microbiol. 29 (1991) 444-448
11. Kelly R. Cultivation of Borrelia hermsi. Science 173 (1971) 443-444
12. Stoenner H.G., Dodd T., and Larsen C. Antigenic variation of Borrelia hermsii. J. Exp. Med. 156 (1982) 1297-1311
13. Barbour A.G. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57 (1984) 521-525
14. Pollack R.J., Telford III S.R., and Spielman A. Standardization of medium for culturing Lyme disease spirochetes. J. Clin. Microbiol. 31 (1993) 1251-1255
15. Callister S.M., Case K.L., Agger W.A., Schell R.F., Johnson R.C., and Ellingson J.L. Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi. J. Clin. Microbiol. 28 (1990) 363-365
16. Wang G., Iyer R., Bittker S., Cooper D., Small J., Wormser G.P., et al. Variations in Barbour-Stoenner-Kelly culture medium modulate infectivity and pathogenicity of Borrelia burgdorferi clinical isolates. Infect. Immun. 72 (2004) 6702-6706
17. Schwartz I., Bittker S., Bowen S.L., Cooper D., Pavia C., and Wormser G.P. Polymerase chain reaction amplification of culture supernatants for rapid detection of Borrelia burgdorferi. Eur. J. Clin. Microbiol. Infect. Dis. 12 (1993) 879-882
18. Reed K.D. Laboratory testing for Lyme disease: possibilities and practicabilities. J. Clin. Microbiol. 40 (2002) 319-324
19. Liveris D., Wang G., Girao G., Byrne D.W., Nowakowski J., McKenna D., et al. Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. J. Clin. Microbiol. 40 (2002) 1249-1253
20. Kurtti T.J., Munderloh U.G., Johnson R.C., and Ahlstrand G.G. Colony formation and morphology in Borrelia burgdorferi. J. Clin. Microbiol. 25 (1987) 2054-2058
21. Preac-Mursic V., Wilske B., and Reinhardt S. Culture of Borrelia burgdorferi on six solid media. Eur. J. Clin. Microbiol. Infect. Dis. 10 (1991) 1076-1079
22. Kurtti T.J., Munderloh U.G., Ahlstrand G.G., and Johnson R.C. Borrelia burgdorferi in tick cell culture: growth and cellular adherence. J. Med. Entomol. 25 (1988) 256-261
23. Munderloh U.G., Park Y.J., Dioh J.M., Fallon A.M., and Kurtti T.J. Plasmid modifications in a tick-borne pathogen, Borrelia burgdorferi, cocultured with tick cells. Insect Mol. Biol. 1 (1993) 195-203
24. Hechemy K.E., Samsonoff W.A., Harris H.L., and McKee M. Adherence and entry of Borrelia burgdorferi in Vero cells. J. Med. Microbiol. 36 (1992) 229-238
25. Tylewska-Wierzbanowska S., and Chmielewski T. The isolation of Borrelia burgdorferi spirochetes from clinical material in cell line cultures. Zentralbl. Bakteriol. 286 (1997) 363-370
26. Schmidt B.L. PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin. Microbiol. Rev. 10 (1997) 185-201
27. Wang G. Direct detection methods for Lyme Borrelia, including the use of quantitative assays. Vector Borne Zoonotic Dis. 2 (2002) 223-231
28. Karlsson M. Aspects of the diagnosis of Lyme borreliosis. Scand. J. Infect. Dis. Suppl. 67 (1990) 1-59
29. Arnez M., Pleterski-Rigler D., Ahcan J., Ruzic-Sabljic E., and Strle F. Demographic features, clinical characteristics and laboratory findings in children with multiple erythema migrans in Slovenia. Wien. Klin. Wochenschr. 113 (2001) 98-101
30. Lebech A.M., Hansen K., Brandrup F., Clemmensen O., and Halkier-Sorensen L. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Mol. Diagn. 5 (2000) 139-150
31. Ornstein K., Berglund J., Bergstrom S., Norrby R., and Barbour A.G. Three major Lyme Borrelia genospecies (Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii) identified by PCR in cerebrospinal fluid from patients with neuroborreliosis in Sweden. Scand. J. Infect. Dis. 34 (2002) 341-346
32. Jaulhac B., Chary-Valckenaere I., Sibilia J., Javier R.M., Piemont Y., Kuntz J.L., et al. Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis. Arthritis Rheum. 39 (1996) 736-745
33. Nocton J.J., Dressler F., Rutledge B.J., Rys P.N., Persing D.H., and Steere A.C. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N. Engl. J. Med. 330 (1994) 229-234
34. Brettschneider S., Bruckbauer H., Klugbauer N., and Hofmann H. Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J. Clin. Microbiol. 36 (1998) 2658-2665
35. Schwaiger M., Peter O., and Cassinotti P. Routine diagnosis of Borrelia burgdorferi (sensu lato) infections using a real-time PCR assay. Clin. Microbiol. Infect. 7 (2001) 461-469
36. Courtney J.W., and Massung R.F. Multiplex Taqman PCR assay for rapid detection of Anaplasma phagocytophilum and Borrelia burgdorferi. Ann. N. Y. Acad. Sci. 990 (2003) 369-370
37. Dattwyler R.J., Volkman D.J., Luft B.J., Halperin J.J., Thomas J., and Golightly M.G. Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N. Engl. J. Med. 319 (1988) 1441-1446
38. Wilske B. Diagnosis of lyme borreliosis in Europe. Vector Borne Zoonotic Dis. 3 (2003) 215-227
39. Aberer E., Brunner C., Suchanek G., Klade H., Barbour A., Stanek G., et al. Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue. Ann. Neurol. 26 (1989) 732-737
40. Cretella S., Gordon S., Flavell R.A., and Fikrig E. Evaluation of a Lyme disease enzyme immunoassay using the 41-G fragment of flagellin. Eur. J. Clin. Microbiol. Infect. Dis. 14 (1995) 609-613
41. Masuzawa T., Kurita T., Kawabata H., and Yanagihara Y. Relationship between infectivity and OspC expression in Lyme disease Borrelia. FEMS Microbiol. Lett. 123 (1994) 319-324
42. Da Silva A.M., and Fikrig E. Arthropod- and host-specific gene expression by Borrelia burgdorferi. J. Clin. Invest. 99 (1997) 377-379
43. Schwan T.G., and Piesman J. Vector interactions and molecular adaptations of Lyme disease and relapsing fever spirochetes associated with transmission by ticks. Emerg. Infect. Dis. 8 (2002) 115-121
44. Mathiesen M.J., Christiansen M., Hansen K., Holm A., Asbrink E., and Theisen M. Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis. J. Clin. Microbiol. 36 (1998) 3474-3479
45. Bacon R.M., Biggerstaff B.J., Schriefer M.E., Gilmore Jr. R.D., Philipp M.T., Steere A.C., et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J. Infect. Dis. 187 (2003) 1187-1199
46. Roessler D., Hauser U., and Wilske B. Heterogeneity of BmpA (P39) among European isolates of Borrelia burgdorferi sensu lato and influence of interspecies variability on serodiagnosis. J. Clin. Microbiol. 35 (1997) 2752-2758
47. Roberts W.C., Mullikin B.A., Lathigra R., and Hanson M.S. Molecular analysis of sequence heterogeneity among genes encoding decorin binding proteins A and B of Borrelia burgdorferi sensu lato. Infect. Immun. 66 (1998) 5275-5285
48. Schulte-Spechtel U., Fingerle V., Goettner G., Rogge S., and Wilske B. Molecular analysis of decorin-binding protein A (DbpA) reveals five major groups among European Borrelia burgdorferi sensu lato strains with impact for the development of serological assays and indicates lateral gene transfer of the dbpA gene. Int. J. Med. Microbiol. 296 Suppl 1 (2006) 250-266
49. Golde W.T., Piesman J., Dolan M.C., et al. Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 65 (1997) 882-889
50. Steere A.C., Sikand V.K., Meurice F., et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group N Engl J Med 339 (1998) 209-215
51. Marangoni A., Sambri V., Accardo S., Cavrini F., Mondardini V., Moroni A., et al. A decrease in the immunoglobulin G antibody response against the VlsE protein of Borrelia burgdorferi sensu lato correlates with the resolution of clinical signs in antibiotic-treated patients with early Lyme disease. Clin Vaccine Immunol 13 (2006) 525-529
52. Peltomaa M., McHugh G., and Steere A.C. Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. J. Infect. Dis. 187 (2003) 1178-1186
53. Lahdenne P., Panelius J., Saxen H., Heikkila T., Sillanpaa H., Peltomaa M., et al. Improved serodiagnosis of erythema migrans using novel recombinant borrelial BBK32 antigens. J. Med. Microbiol. 52 (2003) 563-567
54. MiQ 12 Lyme Borreliose : http://www.dghm.org/red/index.html?cname=MIQ.
55. Aguero-Rosenfeld M.E., Nowakowski J., Bittker S., Cooper D., Nadelman R.B., and Wormser G.P. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J. Clin. Microbiol. 34 (1996) 1-9
56. EUCALB. http://www.oeghmp.at/eucalb/diagnosis_serology-minstandards.html.
57. Craft J.E., Grodzicki R.L., and Steere A.C. Antibody response in Lyme disease: evaluation of diagnostic tests. J. Infect. Dis. 149 (1984) 789-795
58. Gomes-Solecki M.J., Dunn J.J., Luft B.J., Castillo J., Dykhuizen D.E., Yang X., et al. Recombinant chimeric Borrelia proteins for diagnosis of Lyme disease. J. Clin. Microbiol. 38 (2000) 2530-2535
59. Dressler F., Whalen J.A., Reinhardt B.N., and Steere A.C. Western blotting in the serodiagnosis of Lyme disease. J. Infect. Dis. 167 (1993) 392-400
60. Wilske B., Schierz G., Preac-Mursic V., von Busch K., Kuhbeck R., Pfister H.W., et al. Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome). J. Infect. Dis. 153 (1986) 304-314
61. Christen H.J., Bartlau N., Hanefeld F., Eiffert H., and Thomssen R. Peripheral facial palsy in childhood--Lyme borreliosis to be suspected unless proven otherwise. Acta Paediatr. Scand. 79 (1990) 1219-1224
62. Tumani H., Nolker G., and Reiber H. Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis. Neurology 45 (1995) 1663-1670
63. Cutler S.J., and Wright D.J. Comparison of immunofluorescence and enzyme linked immunosorbent assays for diagnosing Lyme disease. J. Clin. Pathol. 42 (1989) 869-871
64. Stiernstedt G.T., Granstrom M., Hederstedt B., and Skoldenberg B. Diagnosis of spirochetal meningitis by enzyme-linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. J. Clin. Microbiol. 21 (1985) 819-825
65. Hansen K., and Asbrink E. Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme-linked immunosorbent assay. J. Clin. Microbiol. 27 (1989) 545-551
66. Kaiser R., and Rauer S. Serodiagnosis of neuroborreliosis: comparison of reliability of three confirmatory assays. Infection 27 (1999) 177-182
67. Liang F.T., Jacobson R.H., Straubinger R.K., Grooters A., and Philipp M.T. Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 38 (2000) 4160-4166
68. Rauer S., Spohn N., Rasiah C., Neubert U., and Vogt A. Enzyme-linked immunosorbent assay using recombinant OspC and the internal 14-kDa flagellin fragment for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 36 (1998) 857-861
69. Zachary P. Evaluation de 14 coffrets commerciaux de dépistage de la borréliose de Lyme en France [thèse]. Strasbourg : Université Louis Pasteur; 2000.
70. Baranton G., Postic D., Saint Girons I., Boerlin P., Piffaretti J.C., Assous M., et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int. J. Syst. Bacteriol. 42 (1992) 378-383
71. Wang G., van Dam A.P., Spanjaard L., and Dankert J. Molecular typing of Borrelia burgdorferi sensu lato by randomly amplified polymorphic DNA fingerprinting analysis. J. Clin. Microbiol. 36 (1998) 768-776
72. Norman G.L., Antig J.M., Bigaignon G., and Hogrefe W.R. Serodiagnosis of Lyme borreliosis by Borrelia burgdorferi sensu stricto, B. garinii, and B. afzelii western blots (immunoblots). J. Clin. Microbiol. 34 (1996) 1732-1738
73. Engstrom S.M., Shoop E., and Johnson R.C. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 33 (1995) 419-427
74. Robertson J., Guy E., Andrews N., Wilske B., Anda P., Granstrom M., et al. A European multicenter study of immunoblotting in serodiagnosis of lyme borreliosis. J. Clin. Microbiol. 38 (2000) 2097-2102
75. Jauris-Heipke S., Fuchs R., Motz M., Preac-Mursic V., Schwab E., Soutschek E., et al. Genetic heterogenity of the genes coding for the outer surface protein C [OspC] and the flagellin of Borrelia burgdorferi. Med. Microbiol. Immunol. (Berl.) 182 (1993) 37-50
76. Cinco M., Murgia R., and Costantini C. Prevalence of IgG reactivity in Lyme borreliosis patients versus Borrelia garinii and Borrelia afzelii in a restricted area of Northern Italy. FEMS Immunol. Med. Microbiol. 12 (1995) 217-222
77. Wilske B., Preac-Mursic V., Schierz G., Kuhbeck R., Barbour A.G., and Kramer M. Antigenic variability of Borrelia burgdorferi. Ann. N. Y. Acad. Sci. 539 (1988) 126-143
78. Grodzicki R.L., and Steere A.C. Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease. J. Infect. Dis. 157 (1988) 790-797
79. Hauser U., Lehnert G., and Wilske B. Diagnostic value of proteins of three Borrelia species [Borrelia burgdorferi sensu lato] and implications for development and use of recombinant antigens for serodiagnosis of Lyme borreliosis in Europe. Clin. Diagn. Lab. Immunol. 5 (1998) 456-462
80. Aguero-Rosenfeld M.E., Wang G., Schwartz I., and Wormser G.P. Diagnosis of lyme borreliosis. Clin. Microbiol. Rev. 18 (2005) 484-509
81. Goettner G., Schulte-Spechtel U., Hillermann R., Liegl G., Wilske B., and Fingerle V. Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues. J. Clin. Microbiol. 43 (2005) 3602-3609
82. Guerineau A.L., Dhote R., Christiann F., Rayet P., and Assous M.V. Differentiation between early and late complicated Lyme borreliosis by specific IgG avidity. Lancet 354 (1999) 1096-1097
83. Coyle P.K., Schutzer S.E., Belman A.L., Krupp L.B., and Golightly M.G. Cerebrospinal fluid immune complexes in patients exposed to Borrelia burgdorferi: detection of Borrelia-specific and -nonspecific complexes. Ann. Neurol. 28 (1990) 739-744
84. Schutzer S.E., Coyle P.K., Belman A.L., Golightly M.G., and Drulle J. Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease. Lancet 335 (1990) 312-315
85. Zhong W., Oschmann P., and Wellensiek H.J. Detection and preliminary characterization of circulating immune complexes in patients with Lyme disease. Med. Microbiol. Immunol. (Berl.) 186 (1997) 153-158
86. Brunner M., and Sigal L.H. Immune complexes from serum of patients with lyme disease contain Borrelia burgdorferi antigen and antigen-specific antibodies: potential use for improved testing. J. Infect. Dis. 182 (2000) 534-539
87. Marques A.R., Hornung R.L., Dally L., and Philipp M.T. Detection of immune complexes is not independent of detection of antibodies in Lyme disease patients and does not confirm active infection with Borrelia burgdorferi. Clin Diagn Lab Immunol 2005; 12 : 1036-40. Erratum in : Clin Diagn Lab Immunol 13 (2006) 307
88. Nohlmans M.K., Blaauw A.A., van den Bogaard A.E., and van Boven C.P. Evaluation of nine serological tests for diagnosis of Lyme borreliosis. Eur. J. Clin. Microbiol. Infect. Dis. 13 (1994) 394-400
89. Pavia C.S., Wormser G.P., Bittker S., and Cooper D. An indirect hemagglutination antibody test to detect antibodies to Borrelia burgdorferi in patients with Lyme disease. J. Microbiol. Methods 40 (2000) 163-173
90. Callister S.M., Schell R.F., Case K.L., Lovrich S.D., and Day S.P. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test. J. Infect. Dis. 167 (1993) 158-164
91. Sadziene A., Thompson P.A., and Barbour A.G. In vitro inhibition of Borrelia burgdorferi growth by antibodies. J. Infect. Dis. 167 (1993) 165-172
92. Pavia C.S., Wormser G.P., and Norman G.L. Activity of sera from patients with Lyme disease against Borrelia burgdorferi. Clin. Infect. Dis. 25 Suppl 1 (1997) S25-S30
93. Ikushima M., Matsui K., Yamada F., Kawahashi S., and Nishikawa S.K. Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies. FEMS Immunol. Med. Microbiol. 29 (2000) 15-21
94. Callister S.M., and Schell R.F. Importance of protective borreliacidal antibodies in Lyme disease immunity and serodiagnosis. J. Infect. Dis. 170 (1994) 499-500
95. Dattwyler R.J., Volkman D.J., Luft B.J., Halperin J.J., Thomas J., and Golightly M.G. Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N. Engl. J. Med. 319 (1988) 1441-1446
96. Dressler F., Yoshinari N.H., and Steere A.C. The T-cell proliferative assay in the diagnosis of Lyme disease. Ann. Intern. Med. 115 (1991) 533-539
97. Buechner S.A., Lautenschlager S., Itin P., Bircher A., and Erb P. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea. Arch. Dermatol. 131 (1995) 673-677
98. Huppertz H.I., Mosbauer S., Busch D.H., and Karch H. Lymphoproliferative responses to Borrelia burgdorferi in the diagnosis of Lyme arthritis in children and adolescents. Eur. J. Pediatr. 155 (1996) 297-302
99. Pohl-Koppe A., Kaunicnik A., and Wilske B. Characterization of the cellular and humoral immune response to outer surface protein C and outer surface protein 17 in children with early disseminated Lyme borreliosis. Med. Microbiol. Immunol. (Berl.) 189 (2001) 193-200